SIPPET INVESTIGATORS

(in order of number of randomized patients)

• A. El-Beshlawy, S.A. Habib and N. Omar from Pediatric Hematology Department, Cairo University Pediatric Hospital, Cairo, Egypt  (38 patients);
• M. Elalfy, N. Elbarbary, G. Nevine and S. Abdelghani from Faculty of Medicine, Ain Shams Center, University – Department Pediatrics, Cairo, Egypt (38 patients);
• V. Ramanan and S. Lohade from Jehangir Clinical Development Centre, Department of Hematology, Jehangir Hospital Premises, Pune, India (22 patients);
• P. Eshghi, M. Ahmadinejad and B.H. Panah from Congenital Pediatric Hematologic Disorders Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran (19 patients);
• S. Hanagavadi, M.S. Hanagavadi and M. Kumar from J J M Medical College, Davangere, India (15 patients);
• R. Varadarajan from Centre for Blood Disorders, Chennai, India (15 patients);
• M. Karimi, A. Afrasiabi and Z. Zahedi from Hematology Research Center, Shiraz University of Medical Sciences, Shiraz, Iran (13 patients);
• M.V. Manglani and S.M. Sharma from Lokmanya Tilak Municipal Medical College & General Hospital, Sion, Mumbai, India  (9 patients);
• C. Ross and S. Subramanian from St. John’s Medical College Hospital, Bangalore, India (8 patients);
• G. Young from Children’s Hospital Los Angeles (CHLA), Los Angeles, USA (8 patients);
• T. Seth and R. Saxena from All India Institute of Medical Sciences, Department of Hematology, New Delhi, India (7 patients);
• S. Apte and S. Kannan from Sahyadri Speciality Hospital, Pune, India (6 patients);
• D.M. Nayak and A. Kurien from Melaka Manipal Medical College (Manipal campus), Manipal University, Karnataka, India (6 patients);
• E. Santagostino and M.E. Mancuso from Angelo Bianchi Bonomi Hemophilia and Thrombosis Centre, IRCCS Ca’ Granda Maggiore Policlinico Hospital Foundation, Milan, Italy (6 patients);
• A.C. Sandoval Gonzales and M.T. Pompa from Hospital de Especialidades UMAE, Istituto Mexicano del Seguro Social (IMSS), Monterrey, Mexico (5 patients);
• J.N. Mahlangu and R. Schwyzer from Faculty of Health Sciences, School of Pathology, University of the Witwatersrand, NHLS and Charlotte Maxeke Johannesburg Academic Hospital, Johannesburg, South Africa  (4 patients);
• S. Bonanad and S. Haya from Hospital Universitario La Fe, Unidad Coagulopatias Congenitas, Valencia, Spain  (3 patients);
• M. Cerqueira and A.P. Marques from Centro de Pesquisa Clinica HEMORIO – Instituto Estadual de Hematologia Arthur de Siqueira Cavalcanti, Rio de Janeiro, Brazil (3 patients);
• N.P. Ewing and C. DeGuzman from writing research papers City of Hope National Medical Center, Duarte, California, USA (3 patients);
• C. Male and K. Thom from Medizinische Universität Wien, Department of Paediatrics, Wien, Austria (3 patients);
• T. Owaidah and M.M. Saleh from King Faisal Specialist Hospital and Research Center, Riyadh, Saudi Arabia (3 patients);
• V. Soto Arellano and D. Cortez Salazar from Centro de Hemofilicos del Hospital de Niños Dr. Roberto del Rio, Santiago, Chile (3 patients);
• N.L. Kobrinsky from Sanford Roger Maris Cancer Center, Fargo, North Dakota, USA (2 patients);
• S. Majumdar from University of Mississipi Medical Center, Division of Pediatric Hematology/Oncology, Jackson, Mississippi, USA (2 patients);
• R. Perez Garrido and R. Nuñez Vazquez from Hospital Universitario Virgen del Rocio, Unidad de Hemofilia, Sevilla, Spain (2 patients);
• A. Sachdeva and N. Radhakrishnan from Pediatric Hematology Oncology and Bone Marrow Transplantation Institute For Child Health Sir Ganga Ram Hospital, New Delhi, India (2 patients);
• M. Simpson from Rush Hemophilia & Thrombophilia Center, Rush University Medical Center, Chicago, Illinois, USA (2 patients);
• M. Thomas from Kerala lnstitute of Medical Science, Kerala, India (2 patients);
• E. Zanon and M. Milan from Clinica Medica II, Azienda Ospedaliera di Padova, Centro Emofilia, Padova, Italy (2 patients);
• B. Antmen and I. Sasmaz from Cukurova Universitesi, Tip Fakultesi Pediatrik Hematoloji B.D., Adana, Turkey (1 patient);
• K. Kavakli from Ege Universitesi Tip Fakultesi Cocuk Sagligive Hastalikari Anabilim Dali, Pediatrik Hematoloji Bilim Dali, Izmir, Turkey (1 patient);
• M.J. Manco-Johnson from Hemophilia & Thrombosis Center, University of Colorado Denver, Aurora, Colorado, USA (1 patient);
• M. Martinez from Hospital de Ninos Sor Maria Ludovica La Plata, Servicio de Hematologia, Buenos Aires, Argentina (1 patient);
• E. Marzouka from Hospital de Ninos Dr. Luis Calvo Mackenna, Centro Hemofilico, Santiago, Chile (1 patient);
• M.G. Mazzucconi and C. Santoro from Ematologia, UO Diagnostica Speciale e Terapia delle Malattie dell’Emostasi e della Trombosi, Università Sapienza, Policlinico Umberto I, Rome, Italy (1 patients);
• D. Neme and L. Elhelou from Fundación de la Hemofilia, Buenos Aires, Argentina (1 patient);
• A. Palomo Bravo from Hospital Regional Universitario Carlos Haya, Malaga, Spain (1 patient);
• R. Paredes Aguilera from Instituto National de Pediatria, Ciudad de México, Mexico (1 patient);
• A. Prezotti from Centro de Hematologia e Hemoterapia do Espírito Santo – Hemoes, Vitoria, Brazil (1 patient);
• K. Schmitt and R. Schwarz from Department of Pediatric and Adolescent Medicine, Kepler University Clinic, Linz, Austria (1 patient);
• B.M. Wicklund from Children’s Mercy Hospital, Kansas City, Missouri, USA (1 patient);
• B. Zulfikar and B. Koç from Istanbul Universitesi Cerrahpasa Tip Fakultesi, Pediatrik  Hematoloji B.D., Istanbul, Turkey (1 patient).